SARS-CoV-2 in the Air: What’s Known and What Isn’t
Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.
SARS-CoV-2 in the Air: What’s Known and What Isn’t
SARS-CoV-2 in the Air: What’s Known and What Isn’t
Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.
Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.
Scientists linked hamsters in a Hong Kong pet shop to 50 cases of the Delta variant in what appears to be the second documented occurrence of animals infecting people with SARS-CoV-2.
Only half of volunteers deliberately exposed to SARS-CoV-2 developed an infection. None developed serious symptoms, paving the way for further challenge trials.
Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.
This strain of SARS-CoV-2 is causing new outbreaks in Europe and Asia and may spread slightly faster than the better-known BA.1 Omicron subvariant, although it’s too early to say for sure.
An independent lab fails to replicate results suggesting mammals exposed to pathogens could pass on immunological protections through epigenetic mechanisms.
Madhvi Menon will discuss immune profiling of COVID-19 patients and Jyoti Phatak-Sheldon will highlight the use of RNAscope in situ hybridization in SARS-CoV-2 research.
Dozens of researchers, including myself, worked for years to uncover that swine flu had leapt to humans from a pig in Mexico in 2009. We learned a lot about influenza evolution, pig farming, and outbreak risk along the way.
Jaclyn Winter and Shiladitya DasSarma will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics.
Seven years of surveillance and research revealed the complex history of the H1N1 virus that leapt from pigs to humans and sparked the global swine flu outbreak.
Linda Saif will give a historical overview of SARS spillovers from animals to humans, and Neville Sanjana will describe recent work on a SARS-CoV-2 spike protein variant that increases human infectivity.
Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.
Preliminary data suggest that the newly dubbed Omicron variant may be more infectious than previous versions of the virus, but it will take time to obtain the reliable data needed to answer pressing questions about its biology.
Alejandra Manjarrez, PhD | Nov 10, 2021 | 7 min read
While the weather isn’t currently the dominant factor driving SARS-CoV-2 transmission, experts say that in the future COVID-19 may become a disease of winter.